Kaitlin M. Young
Guelph, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evidence brief on facilitators, barriers and hesitancy of COVID-19 booster doses in Canada.
Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada
Published: October 09, 2024
A Rapid Review Contrasting the Evidence on Avian Influenza A(H5Nx) Clades 2.3.4.4b and 2.3.2.1c in Humans.
Journal: Zoonoses and public health
Published: March 13, 2024
A scoping review of human pathogens detected in untreated human wastewater and sludge.
Journal: Journal of water and health
Published: February 29, 2024
Extended Spectrum β-Lactamase-Producing Enterobacterales of Shrimp and Salmon Available for Purchase by Consumers in Canada-A Risk Profile Using the Codex Framework.
Journal: Antibiotics (Basel, Switzerland)
Published: August 02, 2023
COVID-19 literature surveillance-A framework to manage the literature and support evidence-based decision-making on a rapidly evolving public health topic.
Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada
Published: February 23, 2023
Carbapenem-resistant Escherichia coli from shrimp and salmon available for purchase by consumers in Canada: a risk profile using the Codex framework.
Journal: Epidemiology and infection
Published: August 15, 2022
Zoonotic Babesia: A scoping review of the global evidence.
Journal: PloS one
Published: August 22, 2019
Reasons for palliative treatments in stage III non-small-cell lung cancer: what contribution is made by time-dependent changes in tumour or patient status?
Journal: Current oncology (Toronto, Ont.)
Published: December 31, 2015
Causes of death and subsequent treatment after initial radical or palliative therapy of stage III non-small-cell lung cancer.
Journal: Current oncology (Toronto, Ont.)
Published: December 03, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026